PR Newswire: news distribution, targeting and monitoring
 

Emerging Tumor Markers and Companies Developing Innovative Technologies and Products

 

NEW YORK, Feb. 22, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Emerging Tumor Markers and Companies Developing Innovative Technologies and Products

http://www.reportlinker.com/p0774964/Emerging-Tumor-Markers-and-Companies-Developing-Innovative-Technologies-and-Products.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

Highlights

  • Comprehensive 260-page market and technological assessment.
  • Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as :    - Biochemical Markers   - Oncogenes   - Growth Factors   - Hormones   - Colony Stimulating Factors   - Lymphokines   - Immunohistochemical Stains.
  • Overview of the clinical significance and market needs for both current and emerging tumor markers.
  • Extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.

Contains 260 pages and 30 tables

Table of Contents Major Current And Emerging Cancer Diagnostic Tests

1. Introduction

2. Tumor Marker Classification

3. ACTH

4. Alpha-Fetoprotein (AFP)

5. Beta-2 Microglobulin

6. CA 15-3/27.29

7. CA 19-9

8. CA-125

9. Calcitonin

10. Carcinoembrionic Antigen (CEA)

11. Estrogen and Progesterone Receptors

12. Ferritin

13. Gastrin

14. Human Chorionic Gonadotropin (HCG)

15. Insulin

16. NSE

17. Occult Blood

18. PAP Smear/HPV

19. Prostatic Acid Phosphatase (PAP)

20. Prostate-Specific Antigen (PSA)

21. Squamous Cell Carcinoma Antigen (SCC)

22. T and B Lymphocytes

23. TdT

24. Thyroglobulin

25. Tissue Polypeptide Antigen (TPA)

26. Biochemical Tumor Markers

- ADA

- B-Protein

- PNP

- 5'-Nucleotidase

27. Oncogenes

- Abl/abl-bcr

- AIB1

- BCL-2

- BRCA1

- CD44

- C-fos- C-myb- C-myc- CYP-17- Erb-B- HPC1- N-myc- P40- P51P53- PIK3CA- PTI-1- Ras- Reg- Sis- Src28. Polypeptide Growth Factors- Basic Fibroblast Growth Factor- Beta-TGF- Cachectin (TNT)- Calmodulin- ECFR- Nerve Growth Factor (NGF)- Epidermal Growth Factor (EGF)- Ornithine Decarboxylase- Transferrin- Transforming Growth Factor-Alpha29. Ectopic Hormones30. Colony Stimulating Factors31. Lymphokines- Alpha-Interferon- B Cell Growth Factors- B Cell Growth Factor (BCGF)- Gamma-Interferon- Interleukin-1 (IL-1)- Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor Markers- N-Acetylglucosamine- Actin- Alpha-Actin

- Antineuronal Antibodies

- 7B2

- B72.3

- Bax

- BCD-F9

- BLCA-4

- Blood Group Antigens A,B,H

- CA 50

- CA 72-4/TAG-72

- CA 195

- CA-242

- CA-549

- CAM 26

- CAR-3

- Cathepsin-D

- Chromogranin A and B

- Cluster 1 Antigen

- Cluster-5/5A Antigen

- CTA

- CU18

- DR-70

- DU-PAN-2

- Endometrial Bleeding Associated Factor

- Endostatin

- Epithelial Membrane Antigen

- Feulgen Hydrolysis

- Fibronectin

- FSH

- (1->3)-L-fucosyltransferase

- Gastrin-Releasing Peptide (GRP)

- GDCFP-15

- Glucagon

- Glycoamines

- H23

- Her-2

- Human Carcinoma Antigen

- HPA

- HSP27

- Intermediate Filaments

- Cytokeratins/CK18/Cyfra 21-1- Desmin- Gliofibrillary Acid Protein- Neurofilaments- Vimentin- KA 93- Kinases- KP16D3- LAI- Leukocyte Common Antigen- Lewis Antigens- Lysophosphatidic Acid (LPA)- Ma 695/Ma 552- MABDF3- MAG- ME1- Minactivin- MN/CA9- MSA- Mucin Cancer Antigen (MCA)- Multiple Tumor Suppressor 1- Myosin- NEA-130- NMP22- OA-519- Opiod Peptides- P-glycoprotein- Pancreatic Oncofetal Antigen (POA)- Placental Lactogen- PR92- Proliferative Index, Ki-67- Px- RB Inactivation/Deletion- Ret- SCCL 175- Selectin- Sialic Acid- Sialyl SSEA-1/SLX- SN10- Somatostatin- TA-90- TABA- Tachykinin- TAG 12- TPS- Troponin- Tubulin- VCAM- VEGF- VillenTo order this report:Biopharmaceutical Industry: Emerging Tumor Markers and Companies Developing Innovative Technologies and ProductsMore  Market Research ReportCheck our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

Featured Video

 
  • Print
  • Email
  •   RSS
  • Share it  
  • Blog it  
  • Blog Search  

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Free Investing Newsletter from Investor Uprising!

Learn to navigate the world's financial system and profit from leading companies.  

Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All That Glitters: The Ultimate Gold Report".

Advanced Search
Search
  
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire